Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	30.89	38.23	-29.21
Graham Fair Price	-47.22	1.73	3.29
PEG	-100.00	-0.37	0.00
Price/Book	33.35	0.89	0.66
Price/Cash Flow	inf	0.00	12.27
Prices/Earnings	386.84	26.60	5.46
Price/Sales	118.48	1.78	0.81
Price/FCF	inf	0.00	12.27
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	341.34	0.35	0.08
Operating Margin	-61.47	0.04	-0.09
ROA	-69.29	< 0.005	0.02
ROE	0.03	< 0.005	-72.61
ROIC	0.03	0.01	-62.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.14	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-10.13	1.24	-87.79
EPS QOQ	0.00	-0.72	-100.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.90	-0.38	-57.27
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	34.39	0.00	inf
Days Sales Outstanding (DSO)	19.70	0.00	inf
Inventory Turnover	2.62	0.00	inf
Debt/Capitalization	0.26	0.24	-8.55
Quick Ratio	0.63	-1.06	67.08
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3.97	4.00	0.84
Cash	0.43	-1.24	189.09
Capex	-0.17	n.A.	n.A.
Free Cash Flow	0.22	n.A.	n.A.
Revenue	3.24	2.00	-38.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.28	1.74	36.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.07	15.71	94.70
Naive Interpretation	Member

06 - Financial Health · Weak

Rating